Area of research
Hematology · Rheumatology
Research interest
Research interests include Medicine, Internal medicine, Disease, Anakinra, Adult-onset Still's disease, and Canakinumab.
Clinical and laboratory markers to distinguish VEXAS from Schnitzler's syndrome: data from the AIDA network registries
Application of machine learning techniques to explore the occurrence of macrophage activation syndrome in Still’s disease: results from the GIRRCS AOSD Study Group and the AIDA Network Still’s Disease Registry
The clinical assessment of lung involvement in patients with Still’s disease, results from the multicentre international AIDA Network Still’s Disease Registry
Managing the clinical heterogeneity of patients with Still's disease, from early diagnosis to timely treatment
Unfolding dermatological spectrum of Still’s disease: a cohort study from the International AIDA Network Still’s Disease Registry
Orbital/ocular inflammatory involvement in VEXAS syndrome: Data from the international AIDA network VEXAS registry
Adult-Onset Still’s Disease (AOSD): Advances in Understanding Pathophysiology, Genetics and Emerging Treatment Options
The Systemic Score May Identify Life‐Threatening Evolution in Still Disease: Data from the GIRRCS AOSD‐Study Group and the AIDA Network Still Disease Registry
The role of 18FDG–PET imaging in VEXAS syndrome: a multicentric case series and a systematic review of the literature
Diagnostic capabilities, clinical features, and longitudinal <scp><i>UBA1</i></scp> clonal dynamics of a nationwide <scp>VEXAS</scp> cohort
Still’s disease continuum from childhood to elderly: data from the international AIDA Network Still’s disease registry
Derivation and validation of four patient clusters in Still’s disease, results from GIRRCS AOSD-study group and AIDA Network Still Disease Registry
JAK inhibitors for the treatment of VEXAS syndrome
IL-18 in Autoinflammatory Diseases: Focus on Adult Onset Still Disease and Macrophages Activation Syndrome
Expert consensus on the treatment of patients with adult-onset still's disease with the goal of achieving an early and long-term remission
Efficacy of canakinumab in patients with Still’s disease across different lines of biologic therapy: real-life data from the International AIDA Network Registry for Still’s Disease
Clinical and laboratory features associated with macrophage activation syndrome in Still’s disease: data from the international AIDA Network Still’s Disease Registry
The administration of methotrexate in patients with Still's disease, “real-life” findings from AIDA Network Still Disease Registry
Correction: Clinical and laboratory features associated with macrophage activation syndrome in Still’s disease: data from the international AIDA Network Still’s Disease Registry
The Administration of Methotrexate in Patients with Still's Disease, “Real-Life” Findings from Aida Network Still Disease Registry
Efficacy and safety of tocilizumab in adult-onset Still's disease: Real-life experience from the international AIDA registry
Development and Implementation of the AIDA International Registry for Patients With Still's Disease
Development and Implementation of the AIDA International Registry for Patients With VEXAS Syndrome
Progress in Biological Therapies for Adult-Onset Still’s Disease
Hyperinflammation after anti-SARS-CoV-2 mRNA/DNA vaccines successfully treated with anakinra: Case series and literature review
The Autoinflammatory Diseases Alliance Registry of monogenic autoinflammatory diseases
Autoinflammatory Features in Gouty Arthritis
The revisited role of interleukin-1 alpha and beta in autoimmune and inflammatory disorders and in comorbidities
The treatment of adult-onset Still's disease with anakinra, a recombinant human IL-1 receptor antagonist: a systematic review of literature
Tryptophan Metabolites, Cytokines, and Fatty Acid Binding Protein 2 in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome